{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:24:08Z","timestamp":1790421848119,"version":"4.1.0"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T00:00:00Z","timestamp":1545004800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.02953","type":"journal-article","created":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T05:26:27Z","timestamp":1545024387000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":45,"title":["Selective Effects of mTOR Inhibitor Sirolimus on Na\u00efve and CMV-Specific T Cells Extending Its Applicable Range Beyond Immunosuppression"],"prefix":"10.3389","volume":"9","author":[{"given":"Szilvia","family":"Bak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Tischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Dragon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarina","family":"Ravens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Pape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Koenecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Oelke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Blasczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britta","family":"Maecker-Kolhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britta","family":"Eiz-Vesper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,12,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1056\/NEJMra033540","article-title":"Immunosuppressive drugs for kidney transplantation","volume":"351","author":"Halloran","year":"2004","journal-title":"N Engl J Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1177\/2040620713489842","article-title":"Treatment and management of graft-versus-host disease: improving response and survival","volume":"4","author":"Garnett","year":"2013","journal-title":"Therap Adv Hematol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.cnur.2015.10.008","article-title":"Immunosuppressive therapy in transplantation","volume":"51","author":"Allison","year":"2016","journal-title":"Nurs Clin North Am."},{"key":"B4","first-page":"479","article-title":"Viral infections in transplant recipients","volume":"100","author":"Razonable","year":"2009","journal-title":"Minerva Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"3331","DOI":"10.1182\/blood-2016-01-628982","article-title":"T cells for viral infections after allogeneic hematopoietic stem cell transplant","volume":"127","author":"Bollard","year":"2016","journal-title":"Blood"},{"key":"B6","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1001\/jama.2008.697","article-title":"Cytomegalovirus reactivation in critically ill immunocompetent patients","volume":"300","author":"Limaye","year":"2008","journal-title":"Jama"},{"key":"B7","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.virusres.2010.10.031","article-title":"Human cytomegalovirus immunity and immune evasion","volume":"157","author":"Jackson","year":"2011","journal-title":"Virus Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1097\/00007890-199201000-00013","article-title":"Symptomatic cytomegalovirus disease in the cytomegalovirus antibody seropositive renal transplant recipient treated with OKT3","volume":"53","author":"Hibberd","year":"1992","journal-title":"Transplantation"},{"key":"B9","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/nrclinonc.2012.111","article-title":"T-cell therapy in the treatment of post-transplant lymphoproliferative disease","volume":"9","author":"Bollard","year":"2012","journal-title":"Nat Rev Clin Oncol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"515","DOI":"10.6061\/clinics\/2015(07)09","article-title":"Cytomegalovirus infection in transplant recipients","volume":"70","author":"Azevedo","year":"2015","journal-title":"Clinics"},{"key":"B11","doi-asserted-by":"publisher","first-page":"721","DOI":"10.7164\/antibiotics.28.721","article-title":"Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle","volume":"28","author":"Vezina","year":"1975","journal-title":"J Antibiot."},{"key":"B12","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1111\/j.1600-6143.2011.03473.x","article-title":"Paradoxical aspects of rapamycin immunobiology in transplantation","volume":"11","author":"Ferrer","year":"2011","journal-title":"Am J Transplant."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1097\/01.TP.0000053752.87383.67","article-title":"Superior T-cell suppression by rapamycin and FK506 over rapamycin and cyclosporine A because of abrogated cytotoxic T-lymphocyte induction, impaired memory responses, and persistent apoptosis","volume":"75","author":"Koenen","year":"2003","journal-title":"Transplantation"},{"key":"B14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.biochi.2016.04.016","article-title":"The effect of immunosuppressive molecules on T-cell metabolic reprogramming","volume":"127","author":"Fernandez-Ramos","year":"2016","journal-title":"Biochimie"},{"key":"B15","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nri3198","article-title":"Regulation and function of mTOR signalling in T cell fate decisions","volume":"12","author":"Chi","year":"2012","journal-title":"Nat Rev Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/j.0105-2896.2010.00898.x","article-title":"The role of mTOR in memory CD8 T-cell differentiation","volume":"235","author":"Araki","year":"2010","journal-title":"Immunol Rev."},{"key":"B17","doi-asserted-by":"publisher","first-page":"13683","DOI":"10.1038\/ncomms13683","article-title":"Fatty acid metabolic reprogramming via mTOR-mediated inductions of PPARgamma directs early activation of T cells","volume":"7","author":"Angela","year":"2016","journal-title":"Nat Commun Commun."},{"key":"B18","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.intimp.2004.09.008","article-title":"Decreased cytomegalovirus infection after antilymphocyte therapy in sirolimus-treated renal transplant patients","volume":"5","author":"Ozaki","year":"2005","journal-title":"Int Immunopharmacol Immunopharmacol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1099\/vir.0.066332-0","article-title":"Rapamycin does not inhibit human cytomegalovirus reactivation from dendritic cells in vitro","volume":"95","author":"Glover","year":"2014","journal-title":"J Gen Virol Virol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1182\/blood-2007-01-069294","article-title":"Sirolimus-based graft-versus-host disease prophylaxis protects against cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation: a cohort analysis","volume":"110","author":"Marty","year":"2007","journal-title":"Blood"},{"key":"B21","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.healun.2013.04.010","article-title":"Decreased incidence of cytomegalovirus infection with sirolimus in a post hoc randomized, multicenter study in lung transplantation","volume":"32","author":"Ghassemieh","year":"2013","journal-title":"J Heart Lung Transplant."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/j.transproceed.2008.03.084","article-title":"Reduced risk of cytomegalovirus infection in solid organ transplant recipients treated with sirolimus: a pooled analysis of clinical trials","volume":"40","author":"Demopoulos","year":"2008","journal-title":"Transplant Proc"},{"key":"B23","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature08155","article-title":"mTOR regulates memory CD8 T-cell differentiation","volume":"460","author":"Araki","year":"2009","journal-title":"Nature"},{"key":"B24","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/nature08097","article-title":"Enhancing CD8 T-cell memory by modulating fatty acid metabolism","volume":"460","author":"Pearce","year":"2009","journal-title":"Nature"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.4049\/jimmunol.1001176","article-title":"Cutting edge: rapamycin augments pathogen-specific but not graft-reactive CD8+ T cell responses","volume":"185","author":"Ferrer","year":"2010","journal-title":"J Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"3201","DOI":"10.4049\/jimmunol.166.5.3201","article-title":"Uncoupling p70(s6) kinase activation and proliferation: rapamycin-resistant proliferation of human CD8(+) T lymphocytes","volume":"166","author":"Slavik","year":"2001","journal-title":"J Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.smim.2007.02.008","article-title":"mTOR at the crossroads of T cell proliferation and tolerance","volume":"19","author":"Mondino","year":"2007","journal-title":"Semin Immunol Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.immuni.2010.09.002","article-title":"The mammalian target of rapamycin: linking T cell differentiation, function, and metabolism","volume":"33","author":"Powell","year":"2010","journal-title":"Immunity"},{"key":"B29","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1074\/jbc.M209733200","article-title":"Rapamycin-resistant proliferation of CD8+ T cells correlates with p27kip1 down-regulation and bcl-xL induction, and is prevented by an inhibitor of phosphoinositide 3-kinase activity","volume":"279","author":"Slavik","year":"2004","journal-title":"J Biol Chem."},{"key":"B30","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.it.2014.10.006","article-title":"Intersection of mTOR and STAT signaling in immunity","volume":"36","author":"Saleiro","year":"2015","journal-title":"Trends Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S1074-7613(00)80025-4","article-title":"Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells","volume":"10","author":"Moriggl","year":"1999","journal-title":"Immunity"},{"key":"B32","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S1074-7613(00)80097-7","article-title":"Stat5 activation is uniquely associated with cytokine signaling in peripheral T cells","volume":"11","author":"Moriggl","year":"1999","journal-title":"Immunity"},{"key":"B33","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/nm869","article-title":"Ex vivo induction and expansion of antigen-specific cytotoxic T cells by HLA-Ig-coated artificial antigen-presenting cells","volume":"9","author":"Oelke","year":"2003","journal-title":"Nat Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/cei.12794","article-title":"Granulocyte colony-stimulating factor impairs CD8(+) T cell functionality by interfering with central activation elements","volume":"185","author":"Bunse","year":"2016","journal-title":"Clin Exp Immunol."},{"key":"B35","first-page":"S157","article-title":"Pharmacokinetics of sirolimus in Thai healthy volunteers","volume":"88","author":"Leelahavanichkul","year":"2005","journal-title":"J Med Assoc Thai Chotmaihet Thangphaet."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/j.bbmt.2013.07.015","article-title":"CMV-, EBV- and ADV-specific T cell immunity: screening and monitoring of potential third-party donors to improve post-transplantation outcome","volume":"19","author":"Sukdolak","year":"2013","journal-title":"Biol Blood Marrow Transplant."},{"key":"B37","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/icb.1988.39","article-title":"The surface phenotype of activated T lymphocytes","volume":"66","author":"Kelly","year":"1988","journal-title":"Immunol Cell Biol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12964-016-0160-z","article-title":"T cell exhaustion: from pathophysiological basics to tumor immunotherapy","volume":"15","author":"Catakovic","year":"2017","journal-title":"Cell Commun Signal"},{"key":"B39","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.immuni.2011.04.006","article-title":"A central role for mTOR kinase in homeostatic proliferation induced CD8+ T cell memory and tumor immunity","volume":"34","author":"Li","year":"2011","journal-title":"Immunity"},{"key":"B40","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1111\/ajt.13649","article-title":"Impact of Everolimus and low-dose cyclosporin on cytomegalovirus replication and disease in pediatric renal transplantation","volume":"16","author":"Hocker","year":"2016","journal-title":"Am J Transplant."},{"key":"B41","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/nri2000","article-title":"Graft-versus-host disease","volume":"7","author":"Shlomchik","year":"2007","journal-title":"Nat Rev Immunol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/ejh.12283","article-title":"Naive subset develops the most important alloreactive response among human CD4+ T lymphocytes in human leukocyte antigen-identical related setting","volume":"92","author":"Cherel","year":"2014","journal-title":"Eur J Haematol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3389\/fimmu.2011.00031","article-title":"Chemokines: a new dendritic cell signal for T cell activation","volume":"2","author":"Thaiss","year":"2011","journal-title":"Front Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"2730","DOI":"10.4049\/jimmunol.176.5.2730","article-title":"Prolonged TCR\/CD28 engagement drives IL-2-independent T cell clonal expansion through signaling mediated by the mammalian target of rapamycin","volume":"176","author":"Colombetti","year":"2006","journal-title":"J Immunol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nri1052","article-title":"Cytokine control of memory T-cell development and survival","volume":"3","author":"Schluns","year":"2003","journal-title":"Nat Rev Immunol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3389\/fimmu.2014.00295","article-title":"Impact of inflammatory cytokines on effector and memory CD8+ T cells","volume":"5","author":"Kim","year":"2014","journal-title":"Front Immunol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1189\/jlb.1RU0814-369R","article-title":"microRNAs function in CD8+ T cell biology","volume":"97","author":"Liang","year":"2015","journal-title":"J Leukoc Biol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1080\/15476286.2018.1445959","article-title":"Anti-miRNA oligonucleotides: a comprehensive guide for design","volume":"15","author":"Lima","year":"2018","journal-title":"RNA Biol Biol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/j.celrep.2018.01.040","article-title":"Early TCR signaling induces rapid aerobic glycolysis enabling distinct acute T cell effector functions","volume":"22","author":"Menk","year":"2018","journal-title":"Cell Rep."},{"key":"B50","doi-asserted-by":"publisher","first-page":"13139","DOI":"10.1073\/pnas.1409155111","article-title":"Diversity and clonal selection in the human T-cell repertoire","volume":"111","author":"Qi","year":"2014","journal-title":"Proc Natl Acad Sci USA."},{"key":"B51","doi-asserted-by":"publisher","first-page":"3663","DOI":"10.1038\/s41598-017-03855-x","article-title":"Highly functional T-cell receptor repertoires are abundant in stem memory T cells and highly shared among individuals","volume":"7","author":"Miyama","year":"2017","journal-title":"Sci Rep."},{"key":"B52","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/ni.3686","article-title":"Human gammadelta T cells are quickly reconstituted after stem-cell transplantation and show adaptive clonal expansion in response to viral infection","volume":"18","author":"Ravens","year":"2017","journal-title":"Nat Immunol."},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-017-3826-x","article-title":"State-of-the-art immunosuppression protocols for pediatric renal transplant recipients","author":"Pape","year":"2017","journal-title":"Pediatr Nephrol."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02953\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T05:26:30Z","timestamp":1545024390000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02953\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,17]]},"references-count":53,"alternative-id":["10.3389\/fimmu.2018.02953"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.02953","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,17]]},"article-number":"2953"}}